Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuromuscular
How do you use serum IgG levels when treating with FcRN inhibitors?
Related to
previous question on dosing of rozanolixizumab
Related Questions
How could you utilize neuromuscular ultrasound as a marker of disease progression/treatment response in CIDP?
How do you treat nocturnal leg cramps?
How do you counsel patients on the benefits of immunotherapy for anti-MAG neuropathy?
Do you perform EMG and repetitive nerve stimulation in patients with ocular myasthenia gravis, particularly those who are AChR-positive, to assess for electrophysiological evidence of generalized disease?
When would you refer patients with Parsonage-Turner syndrome for surgical treatment?
Do you consider immunosuppression in patients with a history of Sjogren's disease and clinical features of inclusion body myositis?
How do you identify patients with false positive AcHR antibodies?
What is the stepwise investigation of patients suspected of inflammatory myopathy?
What leads you to suspect that a foot drop is secondary to a myopathy rather than a neuropathic process?
In which clinical scenarios do you find medial and lateral plantar sensory or mixed nerve conduction studies to be valuable?
